INCREASE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENE-EXPRESSION IN HUMAN-LUNG AND BREAST CARCINOMAS
- 1 August 1987
- journal article
- research article
- Vol. 47 (15) , 4043-4046
Abstract
To assess the postulated correlation between plasminogen activators (PAs) and malignancy, we determined the mRNA content for urokinase-type (u-PA) and tissue-type (T-PA) enzymes in a prospective series of 29 primary lung and 27 primary breast carcinomas. Dot blots of total RNAs were hybridized with appropriate cRNA probes under conditions that allow quantitative measurement of the mRNA level for each PA. Most tumors (43 of 56) had a u-PA mRNA content higher than the mean + 1 SD of nonmalignant tissue counterparts. A large, 4- to 20-fold, increase in u-PA mRNA content was demonstrated in 14 of 29 lung carcinomas and in 10 of 27 breast carcinomas. A statistically significant correlation (Fisher''s test, P = 0.007) was found between elevated u-PA mRNA content in lung carcinomas and the presence of regional lymph node metastases. These results are consistent with a role for u-PA in tumor invasiveness and metastatic propensity and may have important prognostic and therapeutic implications.This publication has 4 references indexed in Scilit:
- Identification of a pituitary factor responsible for enhancement of plasminogen activator activity in breast tumor cells.Proceedings of the National Academy of Sciences, 1986
- MULTIPLE FORMS OF PLASMINOGEN-ACTIVATOR IN HUMAN-BREAST TUMORS1985
- INVOLVEMENT OF PLASMINOGEN-ACTIVATOR PRODUCTION WITH TUMOR-METASTASIS IN A RAT MODEL1984
- CONTENT AND CHARACTERIZATION OF PLASMINOGEN ACTIVATORS IN HUMAN-LUNG TUMORS AND NORMAL LUNG-TISSUE1980